Learn More
Medchemexpress LLC Nvp-bsk805 dihydrochloride | 1942919-79-0 | 99.4% | 563.47 | 1 ML

Supplier: Medchemexpress LLC HY14722A10MM/1ML
NVP-BSK805 dihydrochloride is a potent, ATP-competitive JAK2 inhibitor. It targets JAK2 JH1, wild-type JAK2, and FL JAK2 V617F activity, effectively suppressing the growth of JAK2V617F-bearing acute myeloid leukemia cell lines and blocking STAT5 phosphorylation. It also enhances the efficacy of vincristine treatment in drug-resistant cancer cells.
- ATP-competitive inhibitor.
- Highly potent and selective JAK2 inhibitor.
- Inhibits full-length wild-type JAK2 and FL JAK2 V617F activity.
- Suppresses the growth of JAK2V617F-bearing acute myeloid leukemia cell lines.
- Blocks STAT5 phosphorylation.
- Shows bias for JAK2 over JAK1 and JAK3 inhibition.
- Improves P-gp inhibitory activity.
- Increases sensitization of drug-resistant cancer cells to vincristine treatment.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.